Current filters:


Popular Filters

7001 to 7025 of 7177 results

Novo Nordisk opens type 1 diabetes R&D center in Seattle


Danish insulin giant Novo Nordisk (NVO: N) said this morning that it will establish a type 1 diabetes…

DiabetesNovo NordiskPharmaceuticalResearch

FDA lifts hold on Insmed Arikace trial


USA-based biopharma company Insmed’s (Nasdaq CM: INSM) shares leapt 33.7% to $5.08 on Friday, after…

ArikaceBiotechnologyInsmedNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

ShangPharma milestone in Hengrui accord; expands Lilly contract


Leading Chinese R&D outsourcing firm ShangPharma Corp (NYSE: SHP) says that it has reached the first…

Asia-PacificEli LillyJiangsu Hengrui MedicinePharmaceuticalResearchShangPharma

Pharma industry could use a shot in the arm, says Fitch; FT views bribery settlements


2012 will be a critical year for the pharmaceutical industry, as drugmakers struggle with record patent…

FinancialLegalMarkets & MarketingPatentsPharmaceuticalResearch

EMA starts review of Gilenya; guidance on biosimilar interferon beta


The European Medicines Agency has begun a review of the benefits and risks of Swiss drug major Novartis’…

BiotechnologyEuropeGenericsGilenyainterferon betaNeurologicalNovartisPharmaceuticalRegulation

FDA updates Tysabri label relating to anti-JCV


The US Food and Drug Administration on Friday approved a product label change for Tysabri (natalizumab),…

Biogen IdecBiotechnologyElanNeurologicalNorth AmericaPharmaceuticalRegulationTysabri

EMA panel backs Novartis Cushing’s disease drug; Glivec label change


The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

EuropeGlivecNovartisOncologypasireotidePharmaceuticalRare diseasesRegulationSignifor

FDA Advisory thumbs down for Columbia and Watson product


US drugmakers Columbia Laboratories (Nasdaq: CBRX) and Watson Pharmaceuticals (NYSE: WPI) confirmed on…

Columbia LaboratoriesCrinoneNorth AmericaPharmaceuticalRegulationReproductiveWatson PharmaceuticalsWomen's Health

Merck & Co gets positive CHMP opinion for Remicade in new indication


US drug giant Merck & Co (NYSE: MRK) says that announced that the European Medicines Agency’s Committee…

EuropeGastro-intestinalsMerck & CoPharmaceuticalRegulationRemicade

NovaDel regains rights for ondansetron oral spray product


New Jersey, USA-based NovaDel Pharma (OTCBB: NVDL) has announced the termination of certain license agreements…

BioAlliance PharmaLicensingNovaDel PharmaOncologyondansetronPar PharmaceuticalPharmaceuticalTalon Therapeutics

Additional indication for Otsuka’s Abilify in Japan


Japanese drugmaker Otsuka Pharmaceutical (TYO: 4768) said last week that it has received new regulatory…


Merck & Co and Johnson & Johnson settlements


US drug giant Merck & Co (NYSE: MRK) revealed yesterday that it has entered into an agreement to resolve…

FinancialJohnson & JohnsonLegalMerck & CoNeurologicalNorth AmericaPharmaceuticalRisperdalVioxx

Eisai gets Lunesta approval in Japan, launches Fostoin


Japanese drug major Eisai (TYO: 4523) this week received approval from Japan's Ministry of Health, Labor…

Asia-PacificEisaiFostoinLunestaMarkets & MarketingNeurologicalNobelpharmaPharmaceuticalRegulation

FDA backs Gilead’s Viread for children


The US Food and Drug Administration has approved US biotech firm Gilead Sciences (Nasdaq: GILD) Viread…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationViread

Which of 2012's launches will be future blockbusters?


A review of the year's biggest product launches - based on analyst forecasts - reveals a bumper crop…


Challenges facing pain drug developers


Despite a plethora of medications, the pain market remains an area of high unmet need as current therapies…

Markets & MarketingNeurologicalPharmaceuticalResearch

Aspirin role in cervical cancer prevention?


Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center, USA, global health…


FDA’s CRL on dapagliflozin calls for more clinical data


In what comes as no surprise given a negative vote by an Food and Drug Administration advisory panel…

AstraZenecaBristol-Myers SquibbdapagliflozinDiabetesNorth AmericaPharmaceuticalRegulation

Takeda cuts 2,800 jobs as it assimilates Nycomed


Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) yesterday announced strategic measures…

FinancialManagementNycomedPharmaceuticalResearchTakeda Pharmaceuticals

Bayer’s Xarelto OKed in Japan; promising regorafenib data


Bayer Healthcare, a unit of Germany’s Bayer AG (BAY: DE), had a couple of good news item to report…

BayerCardio-vascularOncologyOnyx PharmaceuticalsPharmaceuticalregorafenibRegulationResearchXarelto

Sanofi Pasteur and Vivalis extend MAb accord


French biopharma company Vivalis (NYSE Euronext: VLS) says it has extended the agreement signed in 2010…

Antibiotics and Infectious diseasesLicensingPharmaceuticalResearchSanofiSanofi PasteurVivalis

7001 to 7025 of 7177 results

Back to top